Nathan Evans is a registered patent attorney with Woods Rogers who focuses on intellectual property (IP)—including patents, trademarks, copyrights, and trade secrets—and he assists start-ups and established companies protect and monetize their IP rights.
Based in Charlottesville, Nathan counsels clients in virtually all IP-related topics, including patent preparation and prosecution, opinions, enforcement strategies, litigation, and licensing. He has worked on matters before state and federal district courts, the U.S. Patent & Trademark Office (including the Patent Trial and Appeal Board), the U.S. International Trade Commission, and the Court of Appeals for the Federal Circuit.
In addition to prosecuting many patent applications before the USPTO, and involvement with the post-grant review process, Nathan’s litigation experience includes cases involving the infringement, validity, and enforceability of patents covering AstraZeneca’s Crestor and Eli Lilly’s Zyprexa and Evista pharmaceuticals. In addition to prosecution and litigation regarding chemical compounds and biotechnology, he has participated in matters involving computer software applications, medical devices, networking solutions, cellular phone technology, multilayer plastic films, paper products, pultruded and extruded structural articles, and optical discs (CDs).
Nathan has substantial experience with India’s patent laws and co-chaired an American Bar Association subcommittee on changes to Indian patent law. He also acted as a co-chair of a subcommittee of the Patent System Policy Planning Division Committee. He now serves on the Virginia Bar Association’s IP Council and the Charlottesville Mayor’s Advisory Council on Innovation and Technology, and he is an Ambassador for the Charlottesville Chamber of Commerce. Recently, Nathan was named a “10 Best” Attorney in the Intellectual Property Division by the American Institute of Legal Counsel™.
Nathan also held leadership roles at the American Bar Association, co-chairing subcommittees for compulsory licensing issues and changes to India’s patent law regime, and represented environmental groups, underprivileged defendants, and a political asylum applicant on a pro bono basis.
Nathan double-majored in biology and psychology at the University of Virginia before entering law school. He writes and speaks on various topics, including IP issues generally, patent laws in India, and prescription drug licensing. Nathan was a judge for the 2019 Apex Entrepreneur Challenge Finals, Virginia Tech’s entrepreneurship event. He joined the Woods Rogers Charlottesville office in 2013.
Virginia Bar Association—Intellectual Property Council; Treasurer (2017); Secretary (2018)
Virginia State Bar—Member, IP Section
District of Columbia Bar Association—Member, IP section
Charlottesville Business Innovation Council
Charlottesville Chamber of Commerce—Ambassador
American Intellectual Property Law Association
Charlottesville Mayor’s Advisory Council on Innovation and Technology
- “Advising Entrepreneurs and Emerging Companies on IP-related Issues,” Virginia Law Emerging Companies and Venture Capital Club Meeting, October 2018
- “The Year in Intellectual Property and Information Technology Law,” Virginia Bar Association, July 2018
- “Legal Issues for Startups,” Roanoke Blacksburg Technology Council/RAMP Accelerator, September 2018
- “Using Intellectual Property as a Business Asset,” Woods Rogers Intellectual Property Seminar (Moderator), May 2018
- “Turn Ideas Into Valuable Intellectual Property Assets,” Lynchburg Business, October 2016
- “Patenting Computer Software Applications: The New Wild West,” CBIC Blog, March 2015
- U.S. Supreme Court Patent Decision: Venue Matters
- The Supreme Court’s New Take on Patent Exhaustion
- How to Get a Computer Software Application Patent: Overcoming Persistent Rejections Based on the Supreme Court’s Alice Opinion
- Virginia Is Newest VC Funding Hotspot! How Startups Can Use Legal Counsel to Capture the Opportunity
- “IP Enforcement Webinar,” VirginiaBio, September 2016. Click here to view webinar.
- “Who Owns Your Intellectual Property?” Roanoke Blacksburg Technology Council (RBTC), August 2015
Nathan’s experience highlights include:
- Lead counsel for Petitioner in USPTO post-grant review relating to data privacy software technology. AvePoint, Inc. v. OneTrust, LLC, PGR2018-0056 (Patent Trial and Appeal Board 2018)
- Lead counsel for defendants in litigation relating to shoe technology. Rothy’s, Inc. v. JKM Technologies, LLC et al., 3:18CV00067 (W.D. Va. 2018)
- Lead counsel for plaintiff in litigation relating to e-commerce platform. Case settled favorably. Moore & Giles, Inc. v. Landmark Technology, LLC, 6:18-cv-00052-NKM (W.D. Va. 2018)
- Lead counsel for plaintiff in litigation relating to trademark dispute. Virginia Industrial Plastics, Inc. v. Cabinet Saver LLC (W.D. Va. 2018)
- Lead counsel for plaintiff in litigation relating to medical device technology. Case settled favorably. Human Design Medical, LLC v. My Health, Inc., 1:16-cv-00767 (D. Del. 2016)
- Successfully argued patent claim construction issues in favorable Markman ruling (W.D. Va. 2015)
- Successfully helped defend lucrative electrical engineering patent and license in significant jury trial victory (S.D.N.Y. 2013)
- In re Rosuvastatin Calcium Patent Litigation (D. Del.). Helped successfully obtain determination of infringement, validity, and enforceability of an Orange Book listed patent for AstraZeneca over the drug product Crestor®
- Eli Lilly & Co. v. Zenith Goldline Pharms., Inc. (S.D. Ind., Fed. Cir.). Helped successfully obtain determination of infringement, validity, and enforceability of an Orange Book listed patent for Eli Lilly over the drug product Zyprexa®
- Active in other successful Abbreviated New Drug Application (ANDA) patent infringement litigations defending challenges to pharmaceutical patents, including patents on Eli Lilly and Company’s Evista® pharmaceutical
Lawyer case results depend upon a variety of factors unique to each case. Case results do not guarantee or predict a similar result in any future case undertaken by the lawyer.